Acupuncture from the perspective of evidence-based medicine - options of clinical use based on National Comprehensive Cancer Network (NCCN) guidelines.

Q4 Medicine Klinicka Onkologie Pub Date : 2022-04-15 DOI:10.48095/ccko202294
J. Halámková, R. Dymáčková, D. Adámková Krákorová
{"title":"Acupuncture from the perspective of evidence-based medicine - options of clinical use based on National Comprehensive Cancer Network (NCCN) guidelines.","authors":"J. Halámková, R. Dymáčková, D. Adámková Krákorová","doi":"10.48095/ccko202294","DOIUrl":null,"url":null,"abstract":"BACKGROUND\nAcupuncture is one of the oldest therapeutic methods. The traditional view of acupuncture is represented by influencing energy pathways through stimulation of specific points. The original meridian theory, which works with the assumption of normalization of the flowing energy Qi in the organism is, with increasing evidence, supplemented with information about the bio-logical impact of the use of acupuncture from the perspective of Western medicine. Specific stimulation of particular points on the body leads to the activation of hypothalamus and pituitary gland through neurotransmitters, resulting in a wide range of systemic effects. Stimulation of nerves in the muscle, which then trans-mits a signal to the spinal cord, midbrain, and hypothalamic-pituitary system, releases neurotransmitters, endogenous opioid peptides, or hormones. Stimulation of acupuncture points changes the levels of proinflammatory cytokines, including IL-1-beta, IL-6, IL-17, and TNF-alpha. Currently, according to the National Comprehensive Cancer Network (NCCN) guidelines, the following symptoms are indicated for acupuncture treatment: pain including neuropathic pain, arthralgia, and myalgia, especially in the aromatase inhibitors therapy, nausea, and vomiting, fatigue, vasomotor symptoms in women and vasomotor symptoms in men caused by androgen deprivation therapy. Acupuncture seems to be an effective and safe treatment method for many of the cancer symptoms or the side effects of cancer treatment, but, like any other treatment method, it has its indications and contraindications.\n\n\nPURPOSE\nThis work aims to provide a comprehensive overview of the use of acupuncture in defined indications, according to current international guidelines. Thus, the therapeutic possibilities of symptomatic treatment of cancer and therapy of adverse events of oncological treatment can be extended.","PeriodicalId":35565,"journal":{"name":"Klinicka Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinicka Onkologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48095/ccko202294","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

Abstract

BACKGROUND Acupuncture is one of the oldest therapeutic methods. The traditional view of acupuncture is represented by influencing energy pathways through stimulation of specific points. The original meridian theory, which works with the assumption of normalization of the flowing energy Qi in the organism is, with increasing evidence, supplemented with information about the bio-logical impact of the use of acupuncture from the perspective of Western medicine. Specific stimulation of particular points on the body leads to the activation of hypothalamus and pituitary gland through neurotransmitters, resulting in a wide range of systemic effects. Stimulation of nerves in the muscle, which then trans-mits a signal to the spinal cord, midbrain, and hypothalamic-pituitary system, releases neurotransmitters, endogenous opioid peptides, or hormones. Stimulation of acupuncture points changes the levels of proinflammatory cytokines, including IL-1-beta, IL-6, IL-17, and TNF-alpha. Currently, according to the National Comprehensive Cancer Network (NCCN) guidelines, the following symptoms are indicated for acupuncture treatment: pain including neuropathic pain, arthralgia, and myalgia, especially in the aromatase inhibitors therapy, nausea, and vomiting, fatigue, vasomotor symptoms in women and vasomotor symptoms in men caused by androgen deprivation therapy. Acupuncture seems to be an effective and safe treatment method for many of the cancer symptoms or the side effects of cancer treatment, but, like any other treatment method, it has its indications and contraindications. PURPOSE This work aims to provide a comprehensive overview of the use of acupuncture in defined indications, according to current international guidelines. Thus, the therapeutic possibilities of symptomatic treatment of cancer and therapy of adverse events of oncological treatment can be extended.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
循证医学视角下的针灸——基于国家综合癌症网络(NCCN)指南的临床使用选择
背景:针灸是最古老的治疗方法之一。针灸的传统观点是通过刺激特定的穴位来影响能量通路。随着越来越多的证据,从西方医学的角度补充了针灸对生物影响的信息,原始的经络理论,与生物体中流动的能量气的正常化假设一起工作。对身体特定部位的特定刺激,通过神经递质导致下丘脑和脑垂体的激活,从而产生广泛的全身效应。刺激肌肉中的神经,然后将信号传递到脊髓、中脑和下丘脑-垂体系统,释放神经递质、内源性阿片肽或激素。刺激穴位会改变促炎细胞因子的水平,包括il -1- β、IL-6、IL-17和tnf - α。目前,根据美国国家综合癌症网络(NCCN)指南,针灸治疗应注意以下症状:疼痛包括神经性疼痛、关节痛和肌痛,尤其是芳香化酶抑制剂治疗,以及雄激素剥夺治疗引起的女性和男性的恶心、呕吐、疲劳、血管舒缩症状。对于许多癌症症状或癌症治疗的副作用,针灸似乎是一种有效而安全的治疗方法,但是,像任何其他治疗方法一样,它有它的适应症和禁忌症。目的:本工作旨在根据当前的国际指南,对针灸在明确适应症中的应用进行全面概述。因此,癌症的对症治疗和肿瘤治疗不良事件的治疗可能性可以扩大。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Klinicka Onkologie
Klinicka Onkologie Medicine-Oncology
CiteScore
1.00
自引率
0.00%
发文量
37
期刊最新文献
Potential application of body fluids autofluorescence in the non-invasive diagnosis of endometrial cancer Factors influencing overall survival and GvHD development after allogeneic hematopoietic stem cell transplantation – single centre experience Prostate cancer invasion is promoted by the miR-96-5p-induced NDRG1 deficiency through NF-κB regulation Tebentafusp in the treatment of metastatic uveal melanoma – the first patient treated in the Czech Republic Feasibility of implementation of the early tumor shrinkage as a potential predictive marker to daily clinical practice in patients with RAS wild type metastatic colorectal cancer, treated with cetuximab – a non-interventional observational study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1